The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

Search for cancer killer leads researchers back to nature

It was heralded as possibly the most powerful cancer drug ever developed.Less than three years after testing the first dose on a human (half the normal testing time for a cancer drug), Novartis Pharmaceuticals presented GleevecTM to the FDA for approval. After a short two-and-a-half month review, FDA officials granted the New Drug Application in May. Twenty-four hours after that, trucks loaded with Gleevec pulled out of Novartis’s warehouse in East Hanover, New Jersey. Novartis boasts that Gleevec enjoyed the fastest time to market of any cancer treatment in American history.

Novartis executives used phrases like “revolutionary drug,” “unsurpassed efficacy,” and “breakthrough cancer therapy” to describe their new product. The chemotherapy agent was specially tailored to combat chronic myeloid leukemia (CML) – a strain of cancer that accounts for 15 percent of all leukemia deaths and usually kills end-stage patients within two to six months. Granted, Gleevec’s preliminary test results were impressive. In early trials, nearly 90 percent of patients with early-stage CML went into remission. The median survival rate among end-stage patients who tried Gleevec, climbed to seven months (traditional chemotherapy generally lets a patient survive two to six months).

And Gleevec improved the quality of CML sufferers’ lives. Novartis acknowledged that the majority of patients treated with Gleevec experienced adverse affects. But unlike standard chemotherapy which assaults the entire immune system, Gleevec targets only the over-active protein that causes CML. Consequently, Gleevec patients suffered notably fewer side-effects than chemo patients.

Enthusiasm for Gleevec soared in the medical community. In the journal Nature, Junia Melo who works on CML at the Imperial College School of Medicine in London, England, said Gleevec’s initial success was so impressive that it left some CML researchers wondering if their careers were over. “It’s the first designer drug for cancer that’s a winner,” Melo said.

But just a few short weeks after the FDA approved Gleevec, researchers discovered the drug didn’t entirely live up to expectations. In fact, the cancer patients who needed it the most – those with advanced CML – were the ones shortchanged. Scientists at the Molecular Biology Institute at UCLA discovered many patients initially responded to the drug, but then relapsed and grew resistant to Gleevec. Lead researcher Charles Sawyer, M.D., explained that the protein at the root of CML actually fought back against the drug. In some cases, the protein’s genetic makeup mutated and rendered the drug useless.

The journal Nature announced the disappointing findings with the headline “Cancer outwits us again.”

The problem is that cancer – and a host of other diseases – have been outwitting pharmaceutical companies for ages. And it’s not surprising. Pharmaceutical companies have set themselves the daunting challenge of trying to extract some miniscule component from nature; re-engineer, alter, fuse and strengthen it; then dispatch it to fix another incredibly complex product of nature — the human body.

The devil, as they say, is in the details. And in the pharmaceutical process, the number of details – and, hence, the number of opportunities for mistake – is infinite.

One thing that natural – and even some conventional -medicine has shown is that health-protecting substances drawn from nature work best when they’re allowed to function the same way they function in their natural state. Remove the ‘active ingredient’ from an herb and often that ingredient won’t produce the same effect. The frustrating truth is that substances don’t work in isolation (a situation that regularly foils our efforts to dissect, extract and control nature). Other components typically boost or expand the medicinal value of a natural substance.

You’ll see one example of this phenomenon in the October issue of the HSI Members Alert. It’s the story of ellagitannin, a substance found in raspberries, walnuts, strawberries, pomegranates, and other fruit. In several published studies, ellagitannin has demonstrated an ability to prevent the growth of cancerous cells and even destroy existing cancer cells. But, as I explained above, ellagitannin works best when you leave it in its natural state.

In tests, Daniel W. Nixon M.D. of the Hollings Cancer Center in South Carolina discovered that the way to get the maximum benefit from this cancer-fighting substance was to pick up some Meeker red raspberries at the market, drop them into a blender, and enjoy the fruit puree. Ellagitannin, extracted from the raspberries, still showed remarkable cancer-fighting abilities. (In one test, cervical cancer cells treated with ellagitannin began to die off with 72 hours.) But the entire raspberry proved even more powerful than the isolated substance. Researchers concluded that other components of the raspberry heightened the effect, but to date, they haven’t been able to identify those components or decipher the interaction.

We aren’t suggesting that ellagitannin is an absolute cure for cancer. If something as simple as a raspberry could cure cancer, the world never would have known its first oncologist. Further, ellagitannin hasn’t yet shown the power to combat a cancer as aggressive as end-stage CML. But the research we’ve uncovered indicates that it may bolster your natural defenses against developing cancers. And that bolstered immune system can prevent a cell mutation from developing into a malignancy.

HSI Panelist Jon Barron brought the story of ellagitannin to our attention. Working with Healing America, he has developed a supplement made exclusively from the Meeker red raspberries featured in Dr. Nixon’s study. Right now, Healing America’s supply is limited. That is why we are offering e-Alert members this early opportunity to try this promising treatment.

To learn more about ellagitannin, or to try it out for yourself, follow this link to Healing America’s website: http://www.northernnutrition.healingamerica.com. And, look for the October issue of Members Alert for further details on this interesting discovery.

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.